FDA inspection
Primus Pharmaceuticals, Inc.: FDA inspection ending Mar 23, 2018
FDA inspection 1048884 · Scottsdale, AZ
Key facts
| Inspection ID | 1048884 |
|---|---|
| Firm | Primus Pharmaceuticals, Inc. |
| FEI number | 3006052875 |
| Address | 7373 N Scottsdale Rd Ste B200 |
| City | Scottsdale |
| State | AZ |
| ZIP | 85253-3530 |
| Fiscal year | 2018 |
| Inspection end date | Mar 23, 2018 |
| Project area | Unapproved and Misbranded Drugs |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data